Saturday, December 29, 2018

why is this dangerous drug being sold in Trinidad & Tobago? Are we the dumping ground for these drug companies? I need some answers!


Generic Name: etoricoxib
Note: Arcoxia has not been approved by the FDA for the U.S. market. The manufacturer of Arcoxia received a non-approvalable letter from the FDA in April of 2007. This non-approvable letter was due to safety concerns of an increased risk of cardiovascular events (including heart attack and stroke) and questions on the benefit-risk ratio in patients taking Arcoxia. Merck will continue to market Arcoxia outside the United States. 

No comments:

Post a Comment